Asia IP - Intellectual Property News and Analysis
Search Result
Hiromi Furushima has joined Isshiki & Partners in Tokyo
Furushima was once GC and head of IP at Novartis Pharma KK in Japan.
Novartis v. Natco imparts clarity on examination and opposition process under Patents Act being parallel but independent
In a decision dated January 9, 2024, the Delhi High Court clarified that the examination and opposit...
Analysis on the protection of a well-known drug trademark
China’s court recognizes Novartis in Chinese as a well-known trademark
Entresto patent restoration in India raises questions about pre-grant opposition – IP attorney
: Questions revolve around the patent office’s broad policy framework and practices
Trust in Change
Lossignol: IP professionals must help improve consumer trust in brands.